HSBC Holdings
CRSP icon

HSBC Holdings’s CRISPR Therapeutics CRSP Stock Holding History

HSBC Holdings’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$131K Sell
2,787
-10,933
-80% -$577K ﹤0.01% 2712
2025
Q4 		$722K Buy
13,720
+4,114
+43% +$246K ﹤0.01% 2121
2025
Q3 		$605K Buy
9,606
+4,325
+82% +$248K ﹤0.01% 2010
2025
Q2 		$259K Buy
+5,281
New +$204K ﹤0.01% 2541
2025
Q1 		– Sell
-17,496
Closed -$685K – 3084
2024
Q4 		$685K Buy
17,496
+2,426
+16% +$115K ﹤0.01% 1998
2024
Q3 		$709K Sell
15,070
-11,795
-44% -$598K ﹤0.01% 1845
2024
Q2 		$1.45M Buy
+26,865
New +$1.55M ﹤0.01% 1519
2022
Q3 		– Sell
-11,548
Closed -$715K – 2979
2022
Q2 		$715K Sell
11,548
-8,324
-42% -$489K ﹤0.01% 2110
2022
Q1 		$1.26M Buy
19,872
+1,333
+7% +$83.7K ﹤0.01% 1808
2021
Q4 		$1.42M Buy
18,539
+5,575
+43% +$487K ﹤0.01% 1847
2021
Q3 		$1.47M Buy
12,964
+1,823
+16% +$229K ﹤0.01% 1683
2021
Q2 		$1.82M Sell
11,141
-2,044
-16% -$249K ﹤0.01% 1484
2021
Q1 		$1.6M Buy
13,185
+2,011
+18% +$304K ﹤0.01% 1387
2020
Q4 		$1.73M Buy
11,174
+6,602
+144% +$780K ﹤0.01% 1389
2020
Q3 		$390K Buy
4,572
+1,820
+66% +$161K ﹤0.01% 2096
2020
Q2 		$202K Sell
2,752
-24,141
-90% -$1.41M ﹤0.01% 2362
2020
Q1 		$1.12M Buy
+26,893
New +$1.39M ﹤0.01% 1413

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GP
GSK plc London $599M AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HSBC Holdings's CRSP Position: Q1 2026 in Review

HSBC Holdings reduced its CRISPR Therapeutics (CRSP) stake by 80% in Q1 2026, selling an estimated $577K and leaving 2,787 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #2712.

HSBC Holdings first reported a position in CRSP in Q1 2020 and has held it in 17 quarters since. The position peaked at $1.82M in Q2 2021. 488 funds tracked by Wall St. Rank hold CRSP as of Q1 2026.

  • HSBC Holdings held 2,787 shares of CRISPR Therapeutics worth $131K as of Q1 2026.
  • HSBC Holdings sold 10,933 CRISPR Therapeutics shares in Q1 2026, an estimated $577K.
  • CRISPR Therapeutics made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2712 holding.
  • HSBC Holdings first reported a position in CRISPR Therapeutics in Q1 2020 and has held it in 17 quarters since.
  • HSBC Holdings's CRISPR Therapeutics position peaked at $1.82M in Q2 2021.
  • 488 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.